Cargando…

Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets

Because of the scale of the novel coronavirus (COVID-19) pandemic and the swift transmission of this highly contagious respiratory virus, repurposing existing drugs has become an urgent treatment approach. The objective of our study is to unravel the binding mechanism of the Food and Drug Administra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arooj, Mahreen, Shehadi, Ihsan, Nassab, Chahlaa N., Mohamed, Ahmed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Versita 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404755/ https://www.ncbi.nlm.nih.gov/pubmed/34483461 http://dx.doi.org/10.1007/s11696-021-01843-0

Ejemplares similares

Modified Graphite Pencil Electrode Based on Graphene Oxide-Modified Fe(3)O(4) for Ferrocene-Mediated Electrochemical Detection of Hemoglobin
por: Elgamouz, Abdelaziz, et al.
Publicado: (2023)

Identification and characterisation of putative drug binding sites in human ATP-binding cassette B5 (ABCB5) transporter
por: Tangella, Lokeswari P., et al.
Publicado: (2020)

Identification of Inhibitor Binding Site in Human Sirtuin 2 Using Molecular Docking and Dynamics Simulations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2013)

Synthesis, Anticancer Evaluation, Computer-Aided Docking Studies, and ADMET Prediction of 1,2,3-Triazolyl-Pyridine Hybrids as Human Aurora B Kinase Inhibitors
por: Rashdan, Huda R.M., et al.
Publicado: (2021)

Homology Modeling and Virtual Screening Studies of Antigen MLAA-42 Protein: Identification of Novel Drug Candidates against Leukemia—An In Silico Approach
por: Shehadi, Ihsan A., et al.
Publicado: (2020)

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
por: Mahmoud, Amal, et al.
Publicado: (2021)

Computational Insights and Virtual Screening of Repurposed FDA-Approved Drug Against SARS-CoV-2 Protease
por: Joel, C., et al.
Publicado: (2023)

Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design
por: Thangapandian, Sundarapandian, et al.
Publicado: (2012)

Solvent-Free Synthesis, In Vitro and In Silico Studies of Novel Potential 1,3,4-Thiadiazole-Based Molecules against Microbial Pathogens
por: Shehadi, Ihsan A., et al.
Publicado: (2022)

Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2
por: Tam, Nguyen Minh, et al.
Publicado: (2021)

Insight the C-Site Pocket Conformational Changes Responsible for Sirtuin 2 Activity Using Molecular Dynamics Simulations
por: Sakkiah, Sugunadevi, et al.
Publicado: (2013)

Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2
por: Fischer, André, et al.
Publicado: (2021)

Green Synthesis, Characterization, Antimicrobial, Anti-Cancer, and Optimization of Colorimetric Sensing of Hydrogen Peroxide of Algae Extract Capped Silver Nanoparticles
por: Elgamouz, Abdelaziz, et al.
Publicado: (2020)

Computational insights into tetracyclines as inhibitors against SARS-CoV-2 M(pro) via combinatorial molecular simulation calculations
por: Bharadwaj, Shiv, et al.
Publicado: (2020)

An Innovative Strategy for Dual Inhibitor Design and Its Application in Dual Inhibition of Human Thymidylate Synthase and Dihydrofolate Reductase Enzymes
por: Arooj, Mahreen, et al.
Publicado: (2013)

Computer-aided drug design for the pain-like protease (PL(pro)) inhibitors against SARS-CoV-2
por: Gao, Hongwei, et al.
Publicado: (2023)

A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors
por: Arooj, Mahreen, et al.
Publicado: (2013)

Computational guided approach for drug repurposing against SARS-CoV-2
por: Anand, Jigisha, et al.
Publicado: (2021)

Drug repurposing against SARS-CoV-2 using computational approaches
por: Kumar, Sumit, et al.
Publicado: (2022)

Recent computational drug repositioning strategies against SARS-CoV-2
por: Lu, Lu, et al.
Publicado: (2022)

Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease
por: Somboon, Tuanjai, et al.
Publicado: (2021)

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach
por: Behera, Santosh Kumar, et al.
Publicado: (2021)

Thermodynamic and structural insights into the repurposing of drugs that bind to SARS-CoV-2 main protease
por: Wan, Shunzhou, et al.
Publicado: (2021)

Binding Mode Analyses and Pharmacophore Model Development for Stilbene Derivatives as a Novel and Competitive Class of α-Glucosidase Inhibitors
por: Lee, Yuno, et al.
Publicado: (2014)

Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries
por: David, Alon Ben, et al.
Publicado: (2021)

Molecular Modeling Study for Inhibition Mechanism of Human Chymase and Its Application in Inhibitor Design
por: Arooj, Mahreen, et al.
Publicado: (2013)

Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease
por: Bosken, Yuliana K., et al.
Publicado: (2020)

Computational repurposing of asthma drugs as potential inhibitors of SARS-CoV-2 M(pro)
por: Hussain, A., et al.
Publicado: (2022)

Design and biological evaluation of 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors
por: Hassan, Abdelfattah, et al.
Publicado: (2023)

Screening of Potent Phytochemical Inhibitors Against SARS-CoV-2 Main Protease: An Integrative Computational Approach
por: Mahmud, Shafi, et al.
Publicado: (2021)

Computational screening for potential drug candidates against the SARS-CoV-2 main protease
por: Silva Andrade, Bruno, et al.
Publicado: (2020)

Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D
por: Martins, Lucas Sousa, et al.
Publicado: (2022)

A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS‐CoV‐2
por: Battisti, Verena, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
por: Sakib, Md Minhas Hossain, et al.
Publicado: (2021)

Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors
por: Rampogu, Shailima, et al.
Publicado: (2023)

Encapsulation Capacity of β-Cyclodextrin Stabilized Silver Nanoparticles towards Creatinine Enhances the Colorimetric Sensing of Hydrogen Peroxide in Urine
por: Elgamouz, Abdelaziz, et al.
Publicado: (2021)

3D QSAR Pharmacophore Modeling, in Silico Screening, and Density Functional Theory (DFT) Approaches for Identification of Human Chymase Inhibitors
por: Arooj, Mahreen, et al.
Publicado: (2011)

Computer-aided drug design for virtual-screening and active-predicting of main protease (M(pro)) inhibitors against SARS-CoV-2
por: Dai, Renhui, et al.
Publicado: (2023)

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors
por: John, Shalini, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9iounud9i05e67a0mscth1vad5